Reduced DNA repair capacity in head and neck cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 6, 1998, Pages 465-468

  Cheng, Lie ^a   Eicher, Susan A ^a   Guo, Zhaozheng ^a   Hong, Waun Ki ^a   Spitz, Margaret R ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA REPAIR; FEMALE; GENETIC SUSCEPTIBILITY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADULT; AGED; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; RISK FACTORS; SMOKING;

EID: 0031879616     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vokes, E. E., Weicheselbaum, R. R., Lippman, S M., and Hong, W. K Head and neck cancer N Engl. J. Med , 328: 184-194, 1993.
2. American Cancer Society, Inc. Cancer Facts & Figures Atlanta: American Cancer Society, 1997.
3. Winn, D. M. Smokeless tobacco and aerodigestive tract cancers: recent research directions In: G. R. Newell and W. K. Hong (eds.), The Biology and Prevention of Aerodigestive Cancers, pp 39-46. New York: Plenum Press, 1992.
4. Macigo, F. G., Mwaniki, D. L., and Guthua, S W Influence of dose and cessation of kiraiku, cigarettes, and alcohol use on the risk of developing oral leukoplakia. Eur. J Oral Sci , 104: 498-502, 1996.
5. Decker, J., and Goldstein, J. C. Risk factors in head and neck cancer N Engl. J. Med , 306: 1151-1155, 1982.
6. Jacob, C. D. Etiologic considerations for head and neck squamous cancers In: C. Jacobs (ed), Carcinomas of the Head and Neck: Evaluation and Management, pp 265-282. Boston: Kluwer Academic, 1990.
7. Lung, V. J , and Howard, D. J. Head and neck cancer in the young: a prognostic conundrum? J. Laryngol. Otol , 104: 544-548, 1990.
8. Ayesh, R., Idle, J. R., Ritchie, J. C , Crothers, M. J., and Hetzel, M R. Metabolic oxidation phenotype as markers for susceptibility to lung cancer Nature (Lond.), 312: 169-170, 1984.
9. Sancer, A DNA repair in humans. Annu Rev Genet., 29: 69-105, 1995.
10. Wei, Q , Cheng, L., Hong, W. K , and Spitz, M. R. Reduced DNA repair capacity in lung cancer patients. Cancer Res , 56: 4103-4107, 1996.
11. Li, D , Wang, M , Cheng, L , Spitz, M. R., Hittelman, W. N , and Wei, Q. In vitro induction of benzo(a)pyrene diol epoxide-induced DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer Cancer Res , 56: 3638-3641, 1996.
12. Hollstein, M , Sidransky, D , Vogelstein, B., and Harris, C. C. p53 mutations in human cancer Science (Washington DC), 53: 49-53, 1991.
13. Greenblatt, M S., Bennett, W P , Hollstein, M., and Harris, C. C. Mutations in p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res , 54: 4855-4878, 1994.
14. Spitz, M. R., Fueger, J J , Beddingfield, N A , Anneger, J. F., Hsu, T. C , Newell, G R , and Schantz, S. P Chromosome sensitivity to bleomycin-induced mutagenesis: an independent risk factor for upper aerodigestive tract cancer Cancer Res., 49: 4626-4628, 1989.
15. MacLeod, M. C , and Tang, M. S Interaction of benzo(a)pyrene-diol-epoxides with linear and supercoiled DNA. Cancer Res., 45: 51-56, 1985.
16. Cosman, M., de los Santos, C., Fiala, R , Hingerty, B. E., Sigh, S. B., Ibanez, V., Margulis, L. A , Live, D., Geacintov, N. E , Broyde, S., and Petel, D. J Solution conformation of the major adducts between the carcinogen (+)-anti-benzo(a)pyrene diol epoxide and DNA. Proc Natl Acad. Sci USA, 89: 1914-1918, 1992.
17. Denissenko, M F , Pao, A , Tang, M., and Pfeifer, G. P. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 430-432, 1996.
18. Tang, M. S., Pierce, J R., Doisy, R. P., Nazimiec, M E., and MacLeod, M C Differences and similarities in the repair of two benzo(a)pyrene diol epoxide isomers induced DNA adducts by uvrA, uvrB, and uvrC gene products. Biochemistry, 31: 8429-8436, 1992.
19. Chen, R. H , Maher, V. M., Brouwer, J., van de Putte, P., and McCormick, J. J. Preferential repair and strand-specific repair of benzo(a)pyrene diol epoxide adducts in HPRT gene of diploid human fibroblasts. Proc. Natl Acad. Sci. USA, 89: 5413-5417, 1992.
20. Everson, R. B., Randerath, E., Santella, R M., Cefalo, R. C., Avitts, T A., and Randerath, K. Detection of smoking-related covalent DNA adducts in human placenta. Science (Washington DC), 231: 54-57, 1986.
21. Perera, F P , Santella, R. M., Brenner, D , Poirier, M. C , Munshi, A. A., Fischman, H. K., and Van Ryzin, J. V. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J. Natl. Cancer Inst , 79: 449-456, 1987.
22. Athas, W. F., Hedayati, M., Matanoski, G. M , Farmer, E R., and Grossman, L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes Cancer Res, 51: 5786-5793, 1991.
23. Wei, Q., Matanoski, G. M., Farmer, E R , Hedayati, M., and Grossman, L DNA repair and aging in basal cell carcinoma, a molecular epidemiologic study. Proc. Natl. Acad. Sci. USA, 90: 1614-1618, 1993.
24. Hudmon, K. S., Honn, S. E., Jiang, H., Chamberlain, R. M., Xiang, W., Ferry, G., Gosbee, W , and Spitz, M. R. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiologic case-control studies of cancer Cancer Epidemiol. Biomark. Prev , 6: 565-571, 1997.
25. Cleaver, J. E., Speakman, J R , and Volpe, J. P G. Nucleotide excision repair: variation associated with cancer development and speciation. Cancer Surv., 25: 125-142, 1995.
26. McCuchan, J. H., and Pagano, J. S. Enhancement of the infectivity of simian virus 40 deoxynbonucleic acid with diethylaminoethyl-dextran J. Natl. Cancer Inst., 41: 351-356, 1968.
27. Protic-Sabljic, M., and Kraemer, K. H One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA, 82: 6622-6626, 1985.
28. Koch, K. S , Fletcher, R. G., Grond, M. P., Inyang, A. I., Lu, X. P , Brenner, D A., and Leffert, H L. Inactivation of plasmid reporter gene expression by one benzo(a)pyrene diol-epoxide DNA adduct in adult rat hepatocytcs Cancer Res., 53: 2279-2286, 1993.
29. Spitz, M. R , Fueger, J J , Halabi, S., Schantz, S. P. Sample, D., and Hsu, T. C Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol. Biomark. Prev., 2: 329-333, 1993.
30. Hsu, T. C., Johnston, D. A., Cherry, L. M., Ramkissoon, D , Schantz, S. P , Jessup, J M , Winn, R J., Shirley, L , and Furlong, C. Sensitivity to genotoxic events of bleomycin in humans possible relationship to environmental carcinogens. Int. J. Cancer, 43: 403-409, 1989.
31. Bondy, M. L. Spitz, M. R., Halabi, S., Fueger, J J , Schantz, S. P , Sample, D., and Hsu, T. C. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol. Biomark. Prev , 2: 103-106, 1993.
32. Spitz, M. R., Hoque, A., Trizna, Z , Schantz, S. P., Amos, C. I , Bondy, M. L , Hong, W. K , and Hsu, T. C Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J. Natl. Cancer Inst., 86: 1681-1684, 1994.
33. Wei, Q., and Spitz, M. R. The role of DNA repair capacity in susceptibility to lung cancer: a review Cancer Metastasis Rev , 16: 295-307, 1997.
34. Wei, Q., Jun, G., Cheng, L , Bondy, M. L , Jiang, H., Hong, W K., and Spitz, M R. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res., 56: 3975-3979, 1996.